2024/08/30 17:25:00 | |
---|---|
Price | |
213.70 SEK | |
Difference | 1.28% (2.70) |
ISIN | SE0000202624 |
Symbol | GETI B |
Exchange | London Stock Exchange European Trade Reporting |
Currency | SEK |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 4,795 EUR |
Benchmark | OMX STOCKHOLM 30 INDEX |
Bid (Bid size) | 211.50 SEK (2,500) |
Ask (Ask size) | 215.90 SEK (2,500) |
Open | 211.40 SEK |
High | 213.70 SEK |
Low | 211.40 SEK |
Close (prev. day) | 211.00 SEK |
VWAP | 180.05 SEK |
Volume (pcs) | - |
Trading volume | - |
Number of trades | 2 |
Last size | - |
Related Futures | 43 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/24 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2024/08/30 17:25:00 | |
---|---|
Price | |
213.70 SEK | |
Difference | 1.28% (2.70) |
ISIN | SE0000202624 |
Symbol | GETI B |
Exchange | London Stock Exchange European Trade Reporting |
Currency | SEK |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 4,795 EUR |
Benchmark | OMX STOCKHOLM 30 INDEX |
Bid (Bid size) | 211.50 SEK (2,500) |
Ask (Ask size) | 215.90 SEK (2,500) |
Open | 211.40 SEK |
High | 213.70 SEK |
Low | 211.40 SEK |
Close (prev. day) | 211.00 SEK |
VWAP | 180.05 SEK |
Volume (pcs) | - |
Trading volume | - |
Number of trades | 2 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | +4.32% | +12.59% | -39.15% |
Perf (abs.) | +8.85 | +23.90 | -137.50 |
Beta | 0.67 | 0.85 | 0.95 |
Volatility | 40.44 | 35.87 | 38.61 |
Ø price 5 days | Ø volume 5 days (pcs.) | 211.29 SEK (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 204.31 SEK (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 200.10 SEK (18) |
Ø price 250 days | Ø volume 250 days (pcs.) | 206.39 SEK (200) |
YTD High | date | 239.70 SEK (2024/04/30) |
YTD Low | date | 175.38 SEK (2024/06/19) |
52 Weeks High | date | 239.70 SEK (2024/04/30) |
52 Weeks Low | date | 175.38 SEK (2024/06/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/08/30 | 22:26 | 18.84 EUR | 0.00 | 1 |
Stuttgart | 2024/08/30 | 16:42 | 18.80 EUR | 0.00 | 6 |
Nasdaq Stockholm | 2024/08/30 | 18:00 | 213.60 SEK | 232.92 | 1,997 |
Munich | 2024/08/30 | 08:20 | 18.575 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2024/08/30 | 17:25 | 213.70 SEK | 0.00 | 2 |
Hanover | 2024/08/30 | 08:01 | 18.685 EUR | 0.00 | 1 |
Frankfurt | 2024/08/30 | 08:10 | 18.58 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/08/26 | 16:51 | 20.60 USD | 0.01 | 2 |
Duesseldorf | 2024/08/30 | 19:31 | 18.64 EUR | 0.00 | 7 |
Berlin | 2024/08/30 | 08:21 | 18.585 EUR | 0.00 | 3 |
GETINGE AB |
- - |
Lindholmspiren 7A - 417 56 Gothenburg |
Telefon: +46-10-335-0000 |
Fax: +46-10-335-5640 |
E-mail: info@getinge.com |
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden. |
Mattias Perjos | Chairman of Managing Board |
Agneta Palmer | Member of Executive Committee |
Anna Romberg | Member of Executive Committee |
Carsten Blecker | Member of Executive Committee |
Elin Frostehav | Member of Executive Committee |
Eric Honroth | Member of Executive Committee |
Joanna Engelke | Member of Executive Committee |
Magnus Lundbäck | Member of Executive Committee |
Stéphane Le Roy | Member of Executive Committee |
Johan Malmquist | Chairman of Supervisory Board |
Carl Reinhold Adolf Bennet | Member of Supervisory Board |
Kristian Samuelsson | Member of Supervisory Board |
Cecilia Margaretha Daun-Wennborg | Member of Supervisory Board |
Dan Frohm | Member of Supervisory Board |
Eva Christina Malin Persson | Member of Supervisory Board |
Fredrik Brattborn | Member of Supervisory Board |
Frida Gustafsson | Member of Supervisory Board |
Johan Bygge | Member of Supervisory Board |
Pontus Kallén | Member of Supervisory Board |
Åke Larsson | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.
The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.